Related Experiment Video

Updated: Aug 22, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Transforming growth factor-beta pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis

Philip J Lucas1, Nicole McNeil, Eva Hilgenfeld

  • 1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Cancer Research
|September 18, 2004
PubMed

Insights

Reduced transforming growth factor-beta signaling in T lymphocytes drives leukemia/lymphoma development. This primary carcinogenic event leads to uncontrolled T-cell proliferation and accumulation of genetic defects.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumorigenesis is a multistep process involving genetic mutations and altered gene regulation.
  • Dysfunctional growth regulation and loss of tumor suppressor gene function contribute to cancer progression.
  • Genomic instability accelerates mutation accumulation, leading to tumor metastasis.

Purpose of the Study:

  • To investigate the role of transforming growth factor-beta signaling in T lymphocytes.
  • To determine if reduced transforming growth factor-beta signaling can initiate leukemic transformation.
  • To analyze the genetic and cellular changes associated with this process.

Main Methods:

  • Utilized transgenic mouse models to study T-cell development and function.
  • Analyzed T-lymphocyte populations, including CD8+ memory T-cells.
  • Performed histological analysis, T-cell receptor monoclonality assessment, and host transferability assays.
  • Conducted spectral karyotype analysis to identify chromosomal aberrations.

Main Results:

  • Reduced transforming growth factor-beta signaling in T lymphocytes caused rapid expansion of CD8+ memory T-cells.
  • This led to the development of leukemia/lymphoma, confirmed by multiple criteria.
  • Tumors exhibited chromosomal aberrations, indicating genomic instability.
  • Reduced transforming growth factor-beta signaling acted as a primary carcinogenic event.

Conclusions:

  • Transforming growth factor-beta signaling is crucial for regulating T-cell proliferation.
  • Its reduction can initiate leukemic transformation by promoting uncontrolled growth and genetic instability.
  • This provides insights into the early events of T-cell leukemia/lymphoma development.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...